Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy

BACKGROUND: Whether adjuvant chemotherapy is beneficial for rectal cancer patients who respond well to neoadjuvant chemoradiotherapy (NCRT) and undergo radical resection is controversial. This study aimed to assess the effect of adjuvant chemotherapy on the oncological outcomes of ypT0-2N0 rectal ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hang, Huang, Ya, Sun, Ge, Zheng, Kuo, Lou, Zheng, Gao, Xian-Hua, Hao, Li-Qiang, Liu, Lian-Jie, Meng, Rong-Gui, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333111/
https://www.ncbi.nlm.nih.gov/pubmed/32647668
http://dx.doi.org/10.21037/atm-20-1278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333111/
https://www.ncbi.nlm.nih.gov/pubmed/32647668
http://dx.doi.org/10.21037/atm-20-1278

Ejemplares similares